313 related articles for article (PubMed ID: 15503433)
1. Influence of the surface properties on nanoparticle-mediated transport of drugs to the brain.
Kreuter J
J Nanosci Nanotechnol; 2004 May; 4(5):484-8. PubMed ID: 15503433
[TBL] [Abstract][Full Text] [Related]
2. Nanoparticulate systems for brain delivery of drugs.
Kreuter J
Adv Drug Deliv Rev; 2001 Mar; 47(1):65-81. PubMed ID: 11251246
[TBL] [Abstract][Full Text] [Related]
3. Apolipoprotein-mediated transport of nanoparticle-bound drugs across the blood-brain barrier.
Kreuter J; Shamenkov D; Petrov V; Ramge P; Cychutek K; Koch-Brandt C; Alyautdin R
J Drug Target; 2002 Jun; 10(4):317-25. PubMed ID: 12164380
[TBL] [Abstract][Full Text] [Related]
4. Nanoparticles as novel carrier for brain delivery: a review.
Agarwal A; Lariya N; Saraogi G; Dubey N; Agrawal H; Agrawal GP
Curr Pharm Des; 2009; 15(8):917-25. PubMed ID: 19275654
[TBL] [Abstract][Full Text] [Related]
5. Nano-enabled delivery systems across the blood-brain barrier.
Hwang SR; Kim K
Arch Pharm Res; 2014 Jan; 37(1):24-30. PubMed ID: 24170511
[TBL] [Abstract][Full Text] [Related]
6. Noninvasive nanoparticle strategies for brain tumor targeting.
Sun C; Ding Y; Zhou L; Shi D; Sun L; Webster TJ; Shen Y
Nanomedicine; 2017 Nov; 13(8):2605-2621. PubMed ID: 28756093
[TBL] [Abstract][Full Text] [Related]
7. [New methods of drug delivery through the blood brain barrier].
Bruhn C
Dtsch Med Wochenschr; 2012 May; 137(21):p18. PubMed ID: 22622506
[No Abstract] [Full Text] [Related]
8. Smart Strategies for Therapeutic Agent Delivery into Brain across the Blood-Brain Barrier Using Receptor-Mediated Transcytosis.
Tashima T
Chem Pharm Bull (Tokyo); 2020; 68(4):316-325. PubMed ID: 32238649
[TBL] [Abstract][Full Text] [Related]
9. Exploiting the properties of biomolecules for brain targeting of nanoparticulate systems.
Cramer S; Rempe R; Galla HJ
Curr Med Chem; 2012; 19(19):3163-87. PubMed ID: 22612701
[TBL] [Abstract][Full Text] [Related]
10. Kinetics of transport of doxorubicin bound to nanoparticles across the blood-brain barrier.
Wohlfart S; Khalansky AS; Gelperina S; Begley D; Kreuter J
J Control Release; 2011 Aug; 154(1):103-7. PubMed ID: 21616104
[TBL] [Abstract][Full Text] [Related]
11. The targeted delivery of cancer drugs across the blood-brain barrier: chemical modifications of drugs or drug-nanoparticles?
Juillerat-Jeanneret L
Drug Discov Today; 2008 Dec; 13(23-24):1099-106. PubMed ID: 18848640
[TBL] [Abstract][Full Text] [Related]
12. Mechanism of polymeric nanoparticle-based drug transport across the blood-brain barrier (BBB).
Kreuter J
J Microencapsul; 2013; 30(1):49-54. PubMed ID: 22676632
[TBL] [Abstract][Full Text] [Related]
13. Drug delivery to the central nervous system by polymeric nanoparticles: what do we know?
Kreuter J
Adv Drug Deliv Rev; 2014 May; 71():2-14. PubMed ID: 23981489
[TBL] [Abstract][Full Text] [Related]
14. Nanoparticles and the blood-brain barrier: advancing from in-vitro models towards therapeutic significance.
Mc Carthy DJ; Malhotra M; O'Mahony AM; Cryan JF; O'Driscoll CM
Pharm Res; 2015 Apr; 32(4):1161-85. PubMed ID: 25446769
[TBL] [Abstract][Full Text] [Related]
15. Effects of apolipoproteins on dalargin transport across the blood-brain barrier.
Shamenkov DA; Petrov VE; Alyautdin RN
Bull Exp Biol Med; 2006 Dec; 142(6):703-6. PubMed ID: 17603675
[TBL] [Abstract][Full Text] [Related]
16. The blood-brain barrier and brain drug delivery.
Koziara JM; Lockman PR; Allen DD; Mumper RJ
J Nanosci Nanotechnol; 2006; 6(9-10):2712-35. PubMed ID: 17048477
[TBL] [Abstract][Full Text] [Related]
17. Advances in nanocarriers enabled brain targeted drug delivery across blood brain barrier.
Sharma G; Sharma AR; Lee SS; Bhattacharya M; Nam JS; Chakraborty C
Int J Pharm; 2019 Mar; 559():360-372. PubMed ID: 30721725
[TBL] [Abstract][Full Text] [Related]
18. Strategies for Enhancing the Permeation of CNS-Active Drugs through the Blood-Brain Barrier: A Review.
Zeiadeh I; Najjar A; Karaman R
Molecules; 2018 May; 23(6):. PubMed ID: 29843371
[No Abstract] [Full Text] [Related]
19. Covalent linkage of apolipoprotein e to albumin nanoparticles strongly enhances drug transport into the brain.
Michaelis K; Hoffmann MM; Dreis S; Herbert E; Alyautdin RN; Michaelis M; Kreuter J; Langer K
J Pharmacol Exp Ther; 2006 Jun; 317(3):1246-53. PubMed ID: 16554356
[TBL] [Abstract][Full Text] [Related]
20. [Research advances in brain-targeted nanoscale drug delivery system].
Liu Y; Jiang C
Yao Xue Xue Bao; 2013 Oct; 48(10):1532-43. PubMed ID: 24417079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
